Artur Karasyov

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Antibody blockade of immune checkpoint regulators such as PD-1 and CTLA4 has been shown to be an effective cancer treatment strategy; however, a large percentage of patients still do not respond to existing therapies. Discovery of additional immune checkpoints and development of antibody therapeutics against them are likely critical to address this unmet(More)
  • 1